Antibodies against Platelet Glycoproteins in Clinically Suspected VITT Patients
Antibodies against Platelet Glycoproteins in Clinically Suspected VITT Patients
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Vaccine-induced thrombotic thrombocytopenia (VITT) is a rare but severe complication following COVID-19 vaccination, marked by thrombocytopenia and thrombosis. Analogous to heparin-induced thrombocytopenia (HIT), VITT shares similarities in anti-platelet factor 4 (PF4) IgG-mediated platelet activation via the FcγRIIa. To investigate the involvement...
Alternative Titles
Full title
Antibodies against Platelet Glycoproteins in Clinically Suspected VITT Patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_eae254c8916047379802a27df9b623a3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eae254c8916047379802a27df9b623a3
Other Identifiers
ISSN
2073-4468
E-ISSN
2073-4468
DOI
10.3390/antib13020035
